‘Inlyta’ applied to national health insurance service this July
‘Inlyta Tab,’ a targeted therapy for renal cancer, will be applied to the national health insurance service this July.
Drug prices of Simponi, a rheumatoid arthritis therapy, and Soliris, a paroxysmal nocturnal hemoglobinuria(PNH) therapy, will get cut due to extended indications.
The Ministry ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.